For people who travel, who are squeamish about injections, or who simply want the lowest-friction option, oral is markedly easier to sustain and adherence is itself a determinant of any benefit
Armed with this genetic insight, patients avoid wasting money on medications or doses that don't match their genetic predisposition, directing treatment resources toward the most effective option for their individual metabolism
Navigating the new diabetes drugs: cardiovascular benefits and when to use The recent introduction of antihyperglycaemic medications that not only improve glycated haemoglobin (HbA1c) levels but also provide cardiovascular, renal and overall mortality benefit renews hope for better management of diabetes
NK is responsible for the integrity of the work as a whole
By incorporating these factors into our model, we aim to provide clinicians with a more accurate and personalized tool for predicting which patients might benefit most from GLP-1 M treatment